Since parkin is widely expressed in various brain regions and neuron types, including cortical neurons and MSNs, (Kitada et al., 1998; Stichel et al., 2000) it is conceivable that the loss of parkin directly induces pathological effects on these neurons and contributes to the pathophysiology of dyskinesia. Here, PRKN is linked to drug-induced dyskinesia.